Social Security whistleblower who claims DOGE mishandled Americans' sensitive data resigns from post

WASHINGTON (AP) — A Social Security official who has filed a whistleblower complaint alleging the Department of Government Efficiency officials Americans' sensitive information says he's resigning his post because of actions taken against him since making his complaint.

LSD shows promise for reducing anxiety in drugmaker's midstage study

WASHINGTON (AP) — reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a that has been banned in the U.S. for more than a half century.

Inside: What's Going on Behind the Scenes in DC? - Ad

Former CIA officer Buck Sexton just met with Trump and VP J.D. Vance - and what he uncovered inside the West Wing is stunning. With ties to Tulsi Gabbard, Mike Johnson, Kash Patel, and more, he's rushing this urgent interview to reveal shocking secrets unfolding behind the scenes right now.

Trump's new CDC chief: A Washington health insider with a libertarian streak

WASHINGTON (AP) — President Donald Trump has picked Jim O’Neill, a former investor and critic of health regulations serving under Health Secretary Robert F. Kennedy Jr., to take control of the Centers for Disease Control and Prevention, following a tumultuous week in which the agency's director was forced out.

US media quickly forced to revisit a thorny question: How should a president's health be covered?

Early in Donald Trump's Tuesday, Fox News' Peter Doocy asked a question that surely baffled people who avoided social media for Labor Day.

October 16 Changes the Microchip Game - and Investing - Ad

George Gilder-dubbed "America's #1 Futurist"-says while everyone's chasing AI, the real opportunity is in a 4-nanometer tech millions of times more complex. It's not another chip - it replaces them. Now built in Arizona, Gilder says 3 companies tied to this "super-convergence" could soar.

AstraZeneca's Fasenra Falls Short In Smoker's Lung Trial

AstraZeneca's Fasenra misses the primary COPD endpoint while Saphnelo's lupus trial shows significant improvements and consistent safety profiles.

The $2.1 Billion Global Market Opportunity In Contrast Media Injectors

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Robert Kennedy Jr. Packs CDC Panel With Vaccine Skeptics Ahead of Key Vote On COVID-19 Shots

Health and Human Services Secretary Robert F. Kennedy Jr. has added five new members to the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices, just days before it reconvenes to vote on COVID-19 shots and other routine pediatric vaccine recommendations.

Abortion advocates raise alarm about social platforms removing posts in apparent overreach

Clinics, advocacy groups and individuals who share abortion-related content online say they are seeing informational posts being taken down even if the posts don't clearly violate the platforms' policies.

[Revealed] Trump's Next AI Executive Orders? - Ad

A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.

Tempus AI Gains FDA Clearance For Updated Pixel To Boost Accuracy And Efficiency In Cardiac Imaging

Tempus AI's Tempus Pixel received FDA clearance for cardiac imaging updates, adding T1/T2 maps to enhance MR image analysis and diagnosis precision.

Trump's plan for a drug advertising crackdown faces many hurdles

WASHINGTON (AP) — Health Secretary Robert F. Kennedy Jr. and other administration officials are vowing a crackdown on deceptive drug ads, but the effort is likely to face multiple headwinds, including pushback from industry and layoffs among regulators tasked with leading the effort.

Analysts Project This Stock Could Jump to $14 a Share. You Can Still Invest for $3.50. - Ad

The AI company making heart disease easier to detect is offering investors $3.50 investment units that include one convertible preferred share and one warrant, providing investors with access to 2 common shares. Based on analyst 1- year projections, that amounts to a near-term 500% return potential.

PTC Therapeutics Could Challenge BioMarin For Metabolic Disorder Treatment

BioMarin's Palynziq significantly lowered blood phenylalanine in teens with PKU, with nearly half reaching target levels in the Phase 3 study.

AstraZeneca Lung Cancer Combo Extends Patient Survival By Years In Key Study

AstraZeneca's Tagrisso with chemotherapy improved survival in advanced NSCLC, extending median overall survival by nearly 10 months over monotherapy.

Is This Elon's Worst Nightmare? - Ad

Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.

Regenxbio Unveils 12-Month Data For Gene Therapy Soon After FDA Delays Review Date

Regenxbio reported sustained biomarker reduction and positive neurodevelopmental outcomes in the pivotal CAMPSIITE trial of RGX-121 for MPS II.

These neurodivergent students are helping each other build more inclusive schools

DENVER (AP) — Engineering student Tory Ridgeway buried his head.

"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad

George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before Oct 16's bombshell.

Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday?

Wave Life Sciences shares early WVE-006 trial results in alpha-1 antitrypsin deficiency, reporting durable protein production and favorable safety.

Trump 'Must Fire' Robert F Kennedy Jr, Calls For Dismissal Get Louder — Don Beyer, Bernie Sanders, Wisconsin's Sara Rodriguez Join The Chorus

Robert F. Kennedy Jr. faces backlash and calls for his removal as HHS Secretary after dismissing CDC Director Susan Monarez and canceling vaccine projects. Rep. Don Beyer and Lt. Gov. Sara Rodriguez urge President Trump to take action.

Gold Alert: Extraordinary Upside in One Stock (Not a Miner) - Ad

Gold has hit all-time highs, breaking $3,600 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.

Novo Nordisk Slowdown Weighs On Denmark's Economic Outlook

Novo Nordisk alone contributing one-fifth of employment gains to Denmark. But economic headwinds are mounting.

More companies pull thousands of packages of shrimp for potential radioactive contamination

More companies are recalling tens of thousands of packages of imported shrimp sold at Walmart, Kroger and other U.S. stores because they may contain according to federal notices.

Did This New AI Just Replace Google? - Ad

Elon Musk's xAI just launched a model that could disrupt Google and even challenge ChatGPT. For the first time, you can stake in xAI with as little as $500 - but you must move before the Oct 1 funding round.

Prothena Reports Non-Competitive Brain Swelling Rates In Early Alzheimer's Study

Prothena reported ASCENT trial data showing strong amyloid plaque reduction but high ARIA-E rates for Alzheimer's drug PRX012, prompting a shift in focus.

Obamacare Subsidies Helping Over 19 Million Could Leave Consumers With 75% Higher Premiums — KFF Warns Of 'Double Whammy'

Insurers propose 18% premium increase for 2026, but enhanced subsidies will expire, leaving consumers facing higher costs. Uncertainty about extension remains.

Could You Use Some Instant Cash Upfront? - Ad

Millionaire trader Jeff Clark's #1 income strategy gives you the chance to collect instant cash payouts, as much as $100 to $1,000 upfront! The great part is you can collect these upfront cash payouts without owning a single stock.... Jeff's put all the details in a special briefing titled Infinite Income Manifesto.

Trump Tariff Fears Envelop Social Security Recipients, 63% Worry About Inflation Rising Above Cost-Of-Living Adjustment

Retirees fear tariffs will erode income, with concerns about Social Security's adequacy. Many struggle even with future COLA increases.

Argenx Immune Disorder Drug's Reach Could Get Much Bigger With Major Trial Win

Argenx advances Vyvgart with strong trial data in seronegative gMG, driving growth projections and reinforcing its leadership in IgG-driven diseases.

Inside: What's Going on Behind the Scenes in DC? - Ad

Former CIA officer Buck Sexton just met with Trump and VP J.D. Vance - and what he uncovered inside the West Wing is stunning. With ties to Tulsi Gabbard, Mike Johnson, Kash Patel, and more, he's rushing this urgent interview to reveal shocking secrets unfolding behind the scenes right now.

Scientists give harsh grades to Trump administration work aimed at undoing a key climate finding

WASHINGTON (AP) — Two key documents from the Trump administration aimed at revoking the long-standing finding that were filled with errors, bias and distortions, according to dozens of scientists surveyed by The Associated Press.

Study says AI chatbots inconsistent in handling suicide-related queries

A study of how three popular artificial intelligence chatbots respond to queries about suicide found that they generally avoid answering questions that pose the highest risk to the user, such as for specific how-to guidance. But they are inconsistent in their replies to less extreme prompts that could still harm people.

October 16 Changes the Microchip Game - and Investing - Ad

George Gilder-dubbed "America's #1 Futurist"-says while everyone's chasing AI, the real opportunity is in a 4-nanometer tech millions of times more complex. It's not another chip - it replaces them. Now built in Arizona, Gilder says 3 companies tied to this "super-convergence" could soar.

To get that perfect ear of corn, weather has to cooperate. But climate change is making it dicier

PAW PAW, Mich. (AP) — Robb Rynd and his brother grew up farming and wanted to do more of it outside their day jobs, so they went in together on what's now a little over 200 acres of corn, soybeans, wheat and sorghum. Last year was a good year, and Rynd said he enjoyed walking the fields with his kids to see how the corn was doing.

North Carolina Supreme Court says bar owners' COVID-19 lawsuits can continue

RALEIGH, N.C. (AP) — The North Carolina Supreme Court issued favorable rulings Friday for bars and their operators in litigation seeking monetary compensation from the state for COVID-19 restrictions first issued by then-Gov. Roy Cooper that shuttered their doors and, in their view, treated them unfairly compared to the way restaurants were regulated.